Travers Smith LLP has advised Bridgepoint Development Capital on its partnership with Prescient Healthcare Group (Prescient), a global product strategy advisory firm serving the pharmaceutical and biotech industries.
Founded in 2007, Prescient is headquartered in London and has offices in the US, India and China. The business provides product strategy services to help its clients make better clinical and commercial decisions, resulting in enhanced outcomes for patients. Prescient works with many of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech and specialty pharmaceutical organisations.
The Travers Smith team was led by Private Equity & Financial Sponsors Partners Ian Shawyer and George Weavil, with support from Private Equity & Financial Sponsors Senior Counsel Jo Roberts, Associates Rachel Taggart, Shannon Anstee and James Ravden, and Trainees Alex Dawson and Jack Meegan. The team also included Finance Partner Donald Lowe, Finance Senior Associate Daniel Domb, Finance Associate Katie Moran, Tax Partners Simon Skinner and Jess Kemp, Tax Senior Associate Joe Sheldrick and Tax Associate Anthony Reeves.
